(Q39225195)
Statements
1 reference
A multicenter phase 1 study of EMD 525797 (DI17E6), a novel humanized monoclonal antibody targeting αv integrins, in progressive castration-resistant prostate cancer with bone metastases after chemotherapy (English)
1 reference
Manfred Wirth
1 reference
Axel Heidenreich
1 reference
Jürgen E Gschwend
1 reference
Thierry Gil
1 reference
Stefan Zastrow
1 reference
Michael Laniado
1 reference
Joachim Gerloff
1 reference
Michael Zühlsdorf
1 reference
Giacomo Mordenti
1 reference
Wolfgang Uhl
1 reference
Heinrich Lannert
1 reference
6 June 2013
1 reference
1 reference
65
1 reference
5
1 reference
897-904
1 reference
Identifiers
1 reference
1 reference